TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 36 filers reported holding TALIS BIOMEDICAL CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 175 | -97.1% | 0.00% | – |
| Q1 2022 | $9,000 | -62.5% | 6,075 | +0.5% | 0.00% | – |
| Q4 2021 | $24,000 | -89.7% | 6,044 | -83.7% | 0.00% | – |
| Q3 2021 | $232,000 | -45.3% | 37,115 | -3.4% | 0.00% | – |
| Q2 2021 | $424,000 | -16.5% | 38,414 | -2.9% | 0.00% | -100.0% |
| Q1 2021 | $508,000 | – | 39,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 1,569,300 | $6,293,000 | 0.36% |
| ArrowMark Colorado Holdings LLC | 4,915,239 | $19,710,000 | 0.16% |
| Baker Brothers Advisors | 7,624,835 | $30,576,000 | 0.15% |
| Golden State Equity Partners | 22,133 | $89,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 188,269 | $755,000 | 0.02% |
| PDT Partners, LLC | 34,890 | $140,000 | 0.01% |
| PERSONAL CFO SOLUTIONS, LLC | 10,000 | $40,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 32,500 | $130,000 | 0.00% |
| Qube Research & Technologies Ltd | 59,161 | $237,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 78,628 | $315,000 | 0.00% |